Michiko Harao
- Immunology top 10%
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 4
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
- Cancer Risks and Factors 2
-
- Breast Cancer Treatment Studies 5
-
- Breast Implant and Reconstruction 9
- Reconstructive Surgery and Microvascular Techniques 7
-
- Ovarian cancer diagnosis and treatment 3
- Co-authors
- Satoru SenjuHideo BabaYasuharu NishimuraKazunori YokomineTakao MizumotoYoshiaki IkutaTakashi FukutomiJun‐ichi Yamashita
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Michiko Harao
35 papers receiving 879 citations
Peers
Comparison fields: 5 of 82
- Immunology 377
- Oncology 329
- Cancer Research 132
- Immunology and Allergy 37
- Pathology and Forensic Medicine 101
Countries citing papers authored by Michiko Harao
This map shows the geographic impact of Michiko Harao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiko Harao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiko Harao more than expected).
Fields of papers citing papers by Michiko Harao
This network shows the impact of papers produced by Michiko Harao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiko Harao. The network helps show where Michiko Harao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michiko Harao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2018 | 1 | |
| 5 | 2017 | 49 | |
| 6 | 2017 | 2 | |
| 7 | 2017 | 1 | |
| 8 | 2017 | 6 | |
| 9 | 2017 | 1 | |
| 10 | A Simple and Practical Method for Setting Up a Criterion of Projection of Silicone Breast Implant After Simple Mastectomy. | 2017 | 2 |
| 11 | 2014 | 21 | |
| 12 | 2010 | 28 | |
| 13 | 2010 | 69 | |
| 14 | 2010 | 29 | |
| 15 | 2009 | 16 | |
| 16 | 2009 | 50 | |
| 17 | 2008 | 90 | |
| 18 | 2008 | 71 | |
| 19 | 2006 | 108 | |
| 20 | 2005 | 19 |
About Michiko Harao
Michiko Harao is a scholar working on Oncology, Cancer Research and Immunology, having authored 36 papers that have together received 915 indexed citations. Recurring topics across this work include Breast Implant and Reconstruction (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Reconstructive Surgery and Microvascular Techniques (7 papers), Breast Cancer Treatment Studies (5 papers), Immune Cell Function and Interaction (4 papers), Ovarian cancer diagnosis and treatment (3 papers) and Cancer Risks and Factors (2 papers). The work is most often cited by research in Immunology (377 citations), Oncology (329 citations) and Cancer Research (132 citations). Michiko Harao has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Satoru Senju, Hideo Baba, Yasuharu Nishimura, Kazunori Yokomine, Takao Mizumoto, Yoshiaki Ikuta, Takashi Fukutomi, Jun‐ichi Yamashita, Katsunori Imai and Satoshi Takahashi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.